Cystatin C estimated glomerular filtration rate and all-cause and cardiovascular disease mortality risk in the general population: AusDiab study

Author:

Barr Elizabeth LM12,Reutens Anne13,Magliano Dianna J1,Wolfe Rory3,Lu Zhong X4,Sikaris Ken A4,Tanamas Stephanie K1,Atkins Robert13,Chadban Steve5,Shaw Jonathan E1,Polkinghorne Kevan R367

Affiliation:

1. Baker Heart and Diabetes Institute; Melbourne Victoria Australia

2. Menzies School of Health Research; Darwin Northern Territory Australia

3. Department of Epidemiology and Preventive Medicine; Monash University; Melbourne Victoria Australia

4. Melbourne Pathology; Melbourne Victoria Australia

5. Sydney University; Sydney New South Wales Australia

6. Department of Medicine; Monash University; Melbourne Victoria Australia

7. Department of Nephrology; Monash Medical Centre; Melbourne Victoria Australia

Funder

National Health and Medical Research Council Training Fellowship

Victorian Government's Operational Infrastructure Support Program

The Commonwealth Dept of Health and Aged Care

Abbott Australasia Pty Ltd

Alphapharm Pty Ltd

AstraZeneca

Aventis Pharmaceutical

Bristol-Myers Squibb Pharmaceuticals

Eli Lilly (Aust) Pty Ltd

GlaxoSmithKline

Janssen-Cilag (Aust) Pty Ltd

Merck Lipha s.a.

Merck Sharp & Dohme (Aust)

Novartis Pharmaceutical (Aust) Pty Ltd.

Novo Nordisk Pharmaceutical Pty Ltd

Pharmacia and Upjohn Pty Ltd

Pfizer Pty Ltd

Roche Diagnostics

Sanofi Synthelabo (Aust) Pty Ltd.

Servier Laboratories (Aust) Pty Ltd

BioRad Laboratories Pty Ltd

HITECH Pathology Pty Ltd

the Australian Kidney Foundation

Diabetes Australia

Diabetes Australia (Northern Territory)

Department of Health, Queensland

South Australian Department of Human Services

Tasmanian Department of Health and Human Services

Territory Health Services

Victorian Department of Human Services

Victorian OIS Program

Department of Health, Government of Western Australia

Publisher

Wiley

Subject

Nephrology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3